Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: enclosed (41), roofed (14), sheltered (10)

DVdSC (weekly cycles 9 onwards) DaratumumabSC-Bortezomib-Dexamethasone Ver1

Description: Chemotherapy Protocol Myeloma DVd SC (weekly) Bortezomib Daratumumab Dexamethasone Cycles 9 onwards Regimen • Myeloma – Bortezomib with daratumumab and dexamethasone Indication • Daratumumab
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/DVdSC-weekly-cycles-9-onwards-DaratumumabSC-Bortezomib-Dexamethasone-Ver1.pdf

Atezolizumab(1680-28days)

Description: Chemotherapy Protocol GENITOURINARY CANCER Atezolizumab (1680mg-28 days) Regimen • Urothelial– Atezolizumab (1680mg-28 days) Indication • This protocol was developed in response
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Bladdercancer/Atezolizumab1680-28days.pdf

Audit and Risk Committee ToR Jan 2022

Description: Audit and Risk Committee Terms of Reference Date Issued: 27 January 2022 Review Date: January 2023 Document Type: Committee Terms of
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2022-Trust-documents/Audit-and-Risk-Committee-ToR-Jan-2022.pdf

InP-Ifosfamide-Liposomal Doxorubicin (Caelyx) v1

Description: Chemotherapy Protocol SARCOMA IFOSFAMIDE-LIPOSOMAL DOXORUBICIN (Caelyx) In-Patient Regimen Please note this protocol is based on information for the use of the Caelyx
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/InP-Ifosfamide-Liposomal-Doxorubicin-Caelyx-v1.pdf

Endocardial pacemaker - patient information

Description: Information about having an endocardial pacemaker fitted in children.
Url: /Media/UHS-website-2019/Patientinformation/Childhealth/Endocardial-pacemaker-2029-PIL.pdf

Feeding information for infants with congenital heart disease

Description: PARENT INFO Information on feeding for infants with congenital heart disease Contents 03 Introduction 04 What to expect � in the first
Url: /Media/UHS-website-2019/Docs/Services/Child-health/DietaryAdvice/Feeding-information-for-infants-with-congenital-heart-disease.pdf

Prostate high dose rate brachytherapy - patient information

Description: This booklet is a guide for patients who are due to undergo high dose rate (HDR) brachytherapy to the prostate.
Url: /Media/UHS-website-2019/Patientinformation/Scansandx-rays/Prostatehighdoseratebrachytherapy-patientinformation.pdf

Rehab pathway for Msk patients 2016

Description: Rehabilitation Pathway for Complex Musculoskeletal Trauma - June 2016 To date, there has been no rehabilitation pathway written for multi-trauma patients
Url: /Media/SUHTExtranet/WessexTraumaNetwork/Rehab-pathway-for-Msk-patients-2016.pdf

Going home from E1 Ocean ward (young adult) - patient information

Description: This booklet contains information that can help you and your family prepare for you to go home following your stay in
Url: /Media/UHS-website-2019/Patientinformation/Childhealth/Going-home-from-E1-Ocean-ward-young-adult-3634-PIL.pdf

Isatuximab VRD weekly

Description: Chemotherapy Protocol Myeloma Isa-VRD weekly Isatuximab-Lenalidomide-Bortezomib-Dexamethasone (20) Regimen Myeloma – Isa-VRD weekly Isatuximab-Lenalidomide-Bortezomib-Dexamethasone (20
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/Isatuximab-VRD-weekly-Ver1.pdf

391 to 400 of 409

Previous … 37 38 39 40 41 Next